# Belimumab

## Benlysta inj 400mg

##### 

| Title              | Content                                                                                                       |
|:-------------------|:--------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | IBEN                                                                                                          |
| Indications        | Reducing disease activity in adult patients with active autoantibody positive SLE receiving standard therapy. |
| Dosing             | IVD， 10 mg/kg over 1 hour every 2 weeks for the first 3 doses and every 4 weeks thereafter.                  |
| Hepatic Impairment | Dose adjustment not necessary                                                                                 |
| Renal Impairment   | Dose adjustment not necessary                                                                                 |
| Contraindications  | Hypersensitivity.                                                                                             |
| Adverse Effects    | Infections. Hypersensitivity reaction; pyrexia， infusion-related reaction.                                   |
| Pregnancy          | Human (and animal) data suggest risk                                                                          |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                 |

